Bajaj Sarita, Purwar Naincy, Gupta Arvind, Gupta Poonam, Srivastava Anubha
Department of Medicine, MLN Medical College and SRN Hospital, Allahabad, Uttar Pradesh, India.
Indian J Endocrinol Metab. 2016 Nov-Dec;20(6):795-798. doi: 10.4103/2230-8210.192893.
To determine the prevalence of subclinical and overt hypothyroidism in diabetic kidney disease (DKD) and effect of thyroid hormone replacement on progression of DKD.
A prospective cohort study on 41 adult DKD patients who were screened for hypothyroidism. Hypothyroid DKD patients were started on levothyroxine replacement and were reviewed after 3 and 6 months.
Of the total population, 14 (34.1%) cases were hypothyroid, among whom 12 (29.3%) cases were subclinical, and 2 (4.8%) were overt hypothyroidism. Prevalence of hypothyroidism and mean thyroid stimulating hormone levels increased with increasing severity of DKD. There were 2 (14.3%) hypothyroid cases in stage 3b, 4 (28.5%) cases in stage 4, and 8 (57.2%) in stage 5 DKD. The mean estimate glomerular filtration rate (ml/min/1.73 m) at baseline was 13.6 ± 13.3 which increased to 16.4 ± 14.5 and 21.2 ± 15.3 after 3 and 6 months of thyroid hormone replacement therapy (THRT), respectively ( < 0.001).
Hypothyroidism is commonly associated with DKD. Prevalence of hypothyroidism increased with declining renal function. THRT significantly improved renal function in DKD patients with hypothyroidism after 3 and 6 months of therapy.
确定糖尿病肾病(DKD)患者中亚临床甲减和显性甲减的患病率,以及甲状腺激素替代治疗对DKD进展的影响。
对41例成年DKD患者进行前瞻性队列研究,筛查甲减情况。对甲减的DKD患者开始使用左甲状腺素进行替代治疗,并在3个月和6个月后进行复查。
在全部研究对象中,14例(34.1%)为甲减患者,其中12例(29.3%)为亚临床甲减,2例(4.8%)为显性甲减。甲减患病率及促甲状腺激素平均水平随DKD严重程度增加而升高。在DKD 3b期有2例(14.3%)甲减患者,4期有4例(28.5%),5期有8例(57.2%)。甲状腺激素替代治疗(THRT)3个月和6个月后,基线时平均估算肾小球滤过率(ml/min/1.73 m²)分别从13.6±13.3升至16.4±14.5和21.2±15.3(P<0.001)。
甲减常与DKD相关。甲减患病率随肾功能下降而升高。THRT治疗3个月和6个月后,显著改善了甲减DKD患者的肾功能。